Lung volume reduction surgery alters management of pulmonary nodules in patients with severe COPD

被引:23
作者
Ojo, TC
Martinez, F
Paine, R
Christensen, PJ
Curtis, JL
Weg, JG
Kazerooni, EA
Whyte, R
机构
[1] UNIV MICHIGAN, MED CTR, DIV PULM & CRIT CARE MED, ANN ARBOR, MI 48109 USA
[2] UNIV MICHIGAN, MED CTR, THORAC SURG SECT, ANN ARBOR, MI 48109 USA
[3] UNIV MICHIGAN, MED CTR, DEPT RADIOL, ANN ARBOR, MI 48109 USA
[4] VET ADM MED CTR, ANN ARBOR, MI 48105 USA
关键词
lung cancer; lung volume reduction surgery; severe chronic airflow obstruction;
D O I
10.1378/chest.112.6.1494
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To examine the role of lung volume reduction surgery (LVRS) in expanding the treatment options for patients with single pulmonary nodules and emphysema. Methods: Retrospective review of all patients undergoing LVRS at the University of Michigan between January 1995 and June 1996. Those undergoing simultaneous LVRS and resection of a suspected pulmonary malignancy formed the study group and underwent history and physical examination, pulmonary function tests, chest radiography, and high-resolution CT of the chest. If heterogeneous emphysema was found, cardiac imaging and single-photon emission CT perfusion lung scanning were performed. All study patients participated in pulmonary rehabilitation preoperatively. Age-and sex-matched patients who had undergone standard lobectomy for removal of pulmonary: malignancy during the same period formed the control group. Results: Of 75 patients who underwent LVRS, 11 had simultaneous resection of a pulmonary nodule. In 10 patients, the nodules were radiographically apparent with 1 demonstrating central calcification. Histologic evaluation revealed six granulomas, two hamartomas, and three neoplastic lesions (one adenocarcinoma, one squamous cell, and one large cell carcinoma). Preoperative FEV1 was 26.18 +/- 2.49% predicted in the LVRS group and 81.36 +/- 6.07% predicted (p = 0.000001) in the control group, and the FVC was 65.27 +/- 5.17% predicted vs 92.18 +/- 5.53% predicted (p = 0.002). Two LVRS patients had a PaCO2 >45 mm Hg while 11 exhibited oxygen desaturation during a G-min walk test. Postoperative complications occurred in two LVRS patients and three control patients. The mean length of stay in the LVRS group (7.55 +/- 1.10 days) was not different than in the control group (8.81 +/- 1.56 days). Three months after LVRS and simultaneous nodule resection, FEV, rose by 47%, FVC by 25%, and all study patients noted less dyspnea as measured by transitional dyspnea index. Conclusions: Simultaneous LVRS and resection of a suspected bronchogenic carcinoma is feasible and associated with minimal morbidity and significantly improved pulmonary function and dyspnea.
引用
收藏
页码:1494 / 1500
页数:7
相关论文
共 33 条
[1]   SEGMENTAL RESECTION FOR BRONCHOGENIC CARCINOMA - SURGICAL ALTERNATIVE FOR THE COMPROMISED PATIENT [J].
BENNETT, WF ;
SMITH, RA .
ANNALS OF THORACIC SURGERY, 1979, 27 (02) :169-172
[2]   EXERCISE CAPACITY AS A PREDICTOR OF POSTOPERATIVE COMPLICATIONS IN LUNG RESECTION CANDIDATES [J].
BOLLIGER, CT ;
JORDAN, P ;
SOLER, M ;
STULZ, P ;
GRADEL, E ;
SKARVAN, K ;
ELSASSER, S ;
GONON, M ;
WYSER, C ;
TAMM, M ;
PERRUCHOUD, AP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (05) :1472-1480
[3]   BILATERAL PNEUMECTOMY (VOLUME REDUCTION) FOR CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
COOPER, JD ;
TRULOCK, EP ;
TRIANTAFILLOU, AN ;
PATTERSON, GA ;
POHL, MS ;
DELONEY, PA ;
SUNDARESAN, RS ;
ROPER, CL .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (01) :106-119
[4]  
ERRETT LE, 1985, J THORAC CARDIOV SUR, V90, P656
[5]   OPTIMIZING SELECTION OF PATIENTS FOR MAJOR LUNG RESECTION [J].
FERGUSON, MK ;
REEDER, LB ;
MICK, R .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (02) :275-283
[6]   Contribution of lung and chest wall mechanics following emphysema resection [J].
Gelb, AF ;
McKenna, RJ ;
Brenner, M ;
Fischel, R ;
Baydur, A ;
Zamel, N .
CHEST, 1996, 110 (01) :11-17
[7]  
Ginsberg Robert J., 1995, Annals of Thoracic Surgery, V60, P615, DOI 10.1016/0003-4975(95)00537-U
[8]  
GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457
[9]  
GUYATT GH, 1985, CAN MED ASSOC J, V132, P919
[10]  
HOFFMANN TH, 1980, J THORAC CARDIOV SUR, V79, P211